LUCD
Lucid Diagnostics Inc.
1W: -8.8%
1M: -9.4%
3M: +12.6%
YTD: +11.6%
1Y: -16.7%
3Y: -29.4%
$1.25
-0.03 (-2.34%)
After Hours: $1.28 (+0.03, +2.80%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$127.2M
52W Range0.95-1.8
Volume668,594
Avg Volume1,304,016
Beta1.18
Dividend—
Analyst Ratings
Company Info
CEOLishan Aklog
Employees72
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-10-14
Websiteluciddx.com
One Grand Central Place
New York City, NY 10165
US
New York City, NY 10165
US
212 949 4319
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Latest News
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
12 Health Care Stocks Moving In Friday's After-Market Session
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Gordon Michael Adam | A-Award | 300,000 | — | 2026-02-20 |
| MCGRATH DENNIS M | A-Award | 470,000 | — | 2026-02-20 |
| O'Neil Shaun | A-Award | 620,000 | — | 2026-02-20 |
| White Debra | A-Award | 123,000 | — | 2026-02-20 |
| Sparks Ronald M | A-Award | 123,000 | — | 2026-02-20 |